Compare MMLP & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMLP | BTMD |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.6M | 90.6M |
| IPO Year | 2002 | N/A |
| Metric | MMLP | BTMD |
|---|---|---|
| Price | $2.60 | $2.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 12.8K | ★ 141.8K |
| Earning Date | 10-15-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $713,263,000.00 | $195,645,000.00 |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $3.27 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $2.49 | $2.32 |
| 52 Week High | $4.02 | $6.90 |
| Indicator | MMLP | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 45.19 |
| Support Level | $2.55 | $2.32 |
| Resistance Level | $2.62 | $2.61 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 0.00 | 54.02 |
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.